What's a man to do? Treatment options for localized prostate cancer

被引:0
|
作者
Pickles, T
机构
[1] British Columbia Canc Agcy, Genitourinary Tumour Grp, Vancouver, BC V5Z 4E6, Canada
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE To describe treatments for localized prostate cancer: surgery, external radiation therapy, and brachytherapy; watchful waiting might also be appropriate. Patients trying to decide about treatment ask family physicians for advice. This article sets out a framework to aid patients (and physicians) in the, decision. QUALITY OF EVIDENCE Only two randomized studies composing of different treatments were identified. Because of the paucity of level I or II evidence, suggestions in this review are largely based on I expert opinion and consensus statements. MAIN MESSAGE Risk-grouping and nomograms are useful for assessing treatments and estimating outcomes of treatment. Where treatments are, equivalent, decisions can be based on perception of toxicity and convenience. Effects on patients' lives and on sexual, urinary, and bowel function vary by treatment modality. CONCLUSION Men with low-risk prostate cancer should decide on treatment based on their perception of how treatment will affect their lives. Men with higher-risk cancers might accept adverse effects on their quality of life in return for longer survival.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 50 条
  • [32] Do patients with localized prostate cancer treatment really want more aggressive treatment?
    van Tol-Geerdink, Julia J.
    Stalmeier, Peep F. M.
    van Lin, Emile N. J. T.
    Schimmel, Eric C.
    Huizenga, Henk
    van Daal, Wim A. J.
    Leer, Jan-Willem
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) : 4581 - 4586
  • [33] Epidemiology, diagnosis and prognosis of localized prostate cancer: What's new?
    Drouin, S. -J.
    Roupret, M.
    PROGRES EN UROLOGIE, 2009, 19 : S3 - S7
  • [34] Do we know what's best for prostate cancer?
    Waxman, J
    Pandha, H
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (09) : 1455 - 1456
  • [35] New Treatment Options for Patients With Metastatic Prostate Cancer: What Is The Optimal Sequence?
    van Dodewaard-de Jong, Joyce M.
    Verheul, Henk M. W.
    Bloemendal, Haiko J.
    de Klerk, John M. H.
    Carducci, Michael A.
    van den Eertwegh, Alfons J. M.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (04) : 271 - 279
  • [36] Castrate-tolerant cells: what are the implications for the treatment of localized prostate cancer?
    Risbridger, Gail
    Taylor, Renea
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (06) : 708 - 708
  • [37] Emerging treatment options for prostate cancer
    Atiq, Mohammad
    Chandran, Elias
    Karzai, Fatima
    Madan, Ravi A.
    Aragon-Ching, Jeanny B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (06) : 625 - 631
  • [38] Metastatic Prostate Cancer: Treatment Options
    Achard, Verane
    Putora, Paul Martin
    Omlin, Aurelius
    Zilli, Thomas
    Fischer, Stefanie
    ONCOLOGY, 2021, : 48 - 59
  • [39] Therapy and treatment options for prostate cancer
    Forjaz, NGD
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 1355 - 1359
  • [40] Treatment options clearer for prostate cancer
    Senior, K
    LANCET, 1998, 352 (9132): : 963 - 963